CureMetrix Competitors and Similar CompaniesClear all

CureMetrix's competitors and similar companies include Poxel, MV Sistemas, iMDSoft and MEDIAN Technologies.

	CureMetrix CureMetrix is committed to the advancement of technology that will improve cancer survival rates worldwide. We are focused on developing the next generation of medical image analysis technology that healthcare providers and patients can confidently rely on.	Poxel Poxelis a research integrated pharmaceutical company that develops products for metabolic diseases.	MV Sistemas MV Sistemas, a Recife, Brazil-based provider of core technology management systems for healthcare.	iMDSoft iMDsoft is a leading provider of Clinical Information Systems for critical, perioperative, and acute care environments.	MEDIAN Technologies MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, cancer screening, and clinical practice.
Founding Date	Founding Date 2014	Founding Date 2009	Founding Date 1987	Founding Date 1999	Founding Date 2002
Type	Type Private	Type Public	Type Private	Type Subsidiary	Type Public
Tags	Tags Healthcare Technology	Tags Healthcare Technology	Tags Healthcare Technology	Tags Healthcare Technology	Tags Healthcare Technology
Locations	Locations San Diego, US HQ	Locations Lyon, FR HQ Chiyoda City, JP Cambridge, US	Locations BR HQ	Locations Dedham, US HQ	Locations Valbonne, FR HQ Wuxi, CN Burlington, US
Employees	Employees 455% increase	Employees 6	Employees 1,9062% increase	Employees 150	Employees 225
Valuation ($)	Valuation ($) N/A	Valuation ($) 18.3 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 76.1 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €6.6m (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €23.4m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods €2.8m (FY, 2024)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit €3.8m (FY, 2024)	Gross profit N/A	Gross profit N/A	Gross profit €24.2m (FY, 2025)
Net income	Net income N/A	Net income (€18.3m) (FY, 2024)	Net income N/A	Net income N/A	Net income (€34.1m) (FY, 2025)